New Research on ALS
Presented at AAN Annual Meeting
A wealth of new research on the causes, risk factors, and potential treatments of ALS was presented at the 60th Annual Meeting of the American Academy of Neurology. Held this year in Chicago, this is the premier meeting of neurologists from around the world, who come to share results of some of the most important new research in neurology.
>> Read full story
Drug Company Working Group
Focuses on New ALS Therapies
Ideas for new ALS treatments come from many different sources. That was the message from The ALS Association’s Drug Company Working Group meeting held in Chicago in April, at the kick-off of the Annual Meeting of the American Academy of Neurology. The research meeting was sponsored by The ALS Association.
>> Read full story
The ALS Association Conference Outlines
The Way Forward in ALS Drug Discovery
By Richard Robinson
Discovering new treatments is a top priority for all ALS researchers. Clinical trials are the endpoint, but long before that, drugs must be discovered and developed. It sounds simple, but in fact, it is one of the most challenging steps in forging new.
>> Read full story
New ALS Gene Paves the Way for
Better Understanding, New Treatments
By Richard Robinson, Science Writer
The discovery of a new gene that causes some forms of ALS will enable the development of new model systems to understand the disease and open the way for development of new treatments. The discovery, to be published today in the journal Science, links mutations in the TDP-43 gene to cases of both familial and sporadic ALS.
>> Read full story
The ALS Association Works with Investigators on
Follow Up Study of Lithium for Treating ALS
[Quick Summary: An Italian study of 44 people reports that a 15-month trial found that daily doses of the drug lithium, used to treat bipolar disorder, significantly slowed the progression of ALS in patients also taking riluzole, the only FDA-approved for the treatment of Lou Gehrig’s disease.]
>> Read full story
Renewed Funding for ALS Biomarker Discovery Highlights Importance of Reliable Disease Indicators
The ALS Association is pleased to announce approval of renewal funding for verification and further analysis of biomarkers in ALS. The studies supported by this grant will build on previous pioneering work to discover new ways to understand and track ALS disease progression.
>> Read full story
See our Research News Archive
for a full list of ALS research news items.
